{'fraction_non_alphanumeric': 0.01580135440180587, 'fraction_numerical': 0.010158013544018058, 'mean_word_length': 5.669172932330827, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Nonconventional mesocaval prosthetic shunt interposition in refractory case with portal hypertension in a 10-kg female infant

Surgical treatment of portal hypertension in infants is challenging because of the high risk of shunt thrombosis. A 10-kg female infant underwent six failed procedures before being successfully treated by interposition of a 10-mm-diameter prosthetic graft between two 3-mm-diameter splanchnic veins and the inferior vena cava. Follow-up at 10 years demonstrates shunt patency and normal development without rebleeding. An aggressive surgical strategy is justified as long as even nonconventional techniques are available to prevent life-threatening complications of portal hypertension. Prosthetic grafts can be used when no autologous vein graft is available. Decellularized allografts with reduced immunogenicity may also be effective alternative materials.